Brind.

Celanese Corporation and Meliodays Medical partnered to develop IUDs using the VitalDose platform.

1 report, 1 independent Updated Jul 29

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Celanese Corporation

Keep exploring

The entities involved

Celanese Corporation
American technology and specialty materials company
- Celanese Corporation announced price increases across Africa, Europe, the Middle East, South America, and North America on September 1, 2026.Sat 05:11

Coverage

Newest first; wire copies grouped

Jul 29GlobeNewswireMeliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain Celanese’s VitalDose® Drug Delivery Platform will enable a long-acting